• 沒有找到結果。

Baicalein Activates Aryl Hydrocarbon Receptor and Decreases the Expression of CDK4 and Cyclin D1 to Induce G1 Phase Arrest in Oral Cancer Cells

N/A
N/A
Protected

Academic year: 2021

Share "Baicalein Activates Aryl Hydrocarbon Receptor and Decreases the Expression of CDK4 and Cyclin D1 to Induce G1 Phase Arrest in Oral Cancer Cells"

Copied!
1
0
0

加載中.... (立即查看全文)

全文

(1)

Baicalein Activates Aryl Hydrocarbon Receptor and Decreases the Expression of CDK4 and Cyclin D1 to Induce G1 Phase Arrest in Oral Cancer Cells

Ya-Hsin Cheng1, Lih-Ann Li2, Pinpin Lin2, Li-Chuan Cheng2, and Chein-Hui Hung3

1

Department of Physiology, School of Medicine, China Medical University, Taiwan, ROC 2

Division of Environmental Health and Occupational Medicine, National Health Research Institutes, Taiwan, ROC

3

Graduate Institute of Clinical Medicine Sciences, Chang Gung University, Taiwan, ROC

Baicalein is a flavonoid known to have anti-inflammatory and anti-cancer effects. Its function as an aryl hydrocarbon receptor (AhR) ligand that modulates AhR-mediated dioxin toxicity was recently proposed. This study investigated if the antiproliferative effect by baicalein was mediated by AhR. The results from MTT assay showed baicalein at concentrations of 7 to 56 μg/ml inhibited cell proliferation in a dose-dependent way in oral cancer cells, HSC-3. Cell cycle analysis showed that baicalein (28μg/ml) arrested cells at G1 phase. The G1 phase arrest in baicalein-treated cells, through the detection of Western blot method, was associated with decreased CDK4, cyclin D1 and retinoblastoma (Rb) phosphorylation. Results from luciferase assay revealed that baicalein activated AhR activity in HSC-3. Furthermore, the

hypophosphorylation of Rb was partially reversed when using siRNA to suppress the expression of AhR in baicalein-treated cells. However, the reduction of CDK4 and cyclin D1 by baicalein was not different between cells with or without AhR knockdown. These data indicate that baicalein inhibits cell proliferation by causing cell cycle arrests at G1 phase. The molecular mechanism of baicalein on G1 phase arrest is mediated by the hypophosphorylation of Rb. The activation of AhR, and the reduction of CDK4 and cyclin D1contributes to the de-phosphorylation of Rb in baicalein treated cells. The data of the study suggest that baicalein can be a chemopreventive agent to inhibit AhR- and cyclin D1-associated cancer cell proliferation.

參考文獻

相關文件

The relation between hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression with anemia and outcome in surgically treated head and neck cancer. De Schutter H, Landuyt

Given that melatonin, due to its free radical scavenging activities and antioxidative actions (3,16,17,39), has been repeatedly shown to reduce the destructive side effects of

Background: The purpose of this study was to evaluate the immunohistochemical expression of NF-κB and IL-6 in oral premalignant and malignant lesions and to

pylori in pathogenesis of oral mucosal lesions or ulcerations is still unclear, it seems that patients with oral lesions as leukoplakia and oral lichen planus, and concurrent

Background: Gold standard for the diagnosis of oral dysplasia (OD) oral squamous cell carcinoma (OSCC) and malignant lesions is the histological examination.. Several

Our case highlights an enigmatic presentation of oral submucous fibrosis and its coexistence with oral cancer presenting with unusual neurological disturbance of the inferior

The purpose of this article is to update oral healthcare practitioners on our current knowledge of the oral microbiome in health and disease, to review how molecular methods

Specific deleterious gene mutation profiles were converted into a computational format and annotated into the HNSCC cancer network, simulated to induce the cell line - specific